- Home
- MESA vs STTK Comparison
MESA vs STTK Comparison
Compare MESA & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- STTK
- Stock Information
- Founded
- MESA 1982
- STTK 2016
- Country
- MESA United States
- STTK United States
- Employees
- MESA N/A
- STTK N/A
- Industry
- MESA Air Freight/Delivery Services
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- STTK Health Care
- Exchange
- MESA Nasdaq
- STTK Nasdaq
- Market Cap
- MESA 42.7M
- STTK 38.4M
- IPO Year
- MESA 2018
- STTK 2020
- Fundamental
- Price
- MESA $1.08
- STTK $0.73
- Analyst Decision
- MESA
- STTK Hold
- Analyst Count
- MESA 0
- STTK 4
- Target Price
- MESA N/A
- STTK $3.00
- AVG Volume (30 Days)
- MESA 126.8K
- STTK 212.4K
- Earning Date
- MESA 08-15-2025
- STTK 08-12-2025
- Dividend Yield
- MESA N/A
- STTK N/A
- EPS Growth
- MESA N/A
- STTK N/A
- EPS
- MESA N/A
- STTK N/A
- Revenue
- MESA $424,030,000.00
- STTK $4,606,000.00
- Revenue This Year
- MESA $39.81
- STTK N/A
- Revenue Next Year
- MESA N/A
- STTK N/A
- P/E Ratio
- MESA N/A
- STTK N/A
- Revenue Growth
- MESA N/A
- STTK 69.65
- 52 Week Low
- MESA $0.68
- STTK $0.69
- 52 Week High
- MESA $1.59
- STTK $4.00
- Technical
- Relative Strength Index (RSI)
- MESA 51.36
- STTK 38.74
- Support Level
- MESA $0.91
- STTK $0.73
- Resistance Level
- MESA $1.18
- STTK $0.92
- Average True Range (ATR)
- MESA 0.06
- STTK 0.07
- MACD
- MESA -0.01
- STTK 0.00
- Stochastic Oscillator
- MESA 36.84
- STTK 1.06
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.